Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Read more about Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
Point-of-Care Ultrasound Educational Initiative for Insect Bites Read more about Point-of-Care Ultrasound Educational Initiative for Insect Bites
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study Read more about Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia Read more about Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma Read more about PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma
Clinical Decision Support for Patient Migraine Management Read more about Clinical Decision Support for Patient Migraine Management
A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD) Read more about A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD)
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Read more about Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer Read more about Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma Read more about Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma